retatrutide cancer for weight loss: Study shows 30% body weight loss Retatrutide—A Game Changer in Obesity

However, no retrospective epidemiological studies can provide definitive answers, and nausea, vomiting and diarrhoea remain the most clinically relevant adverse effects of these drugs, compromising long-term adherence.

If you've turned on the news, opened social media, or spoken with clients lately, you've probably heard a lot about GLP-1 medications

The positive phase 1 clinical trial for Viking Therapeutics Inc

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Discover why some people notice changes, how metabolic shifts during weight loss may contribute, and practical strategies to manage body odour whilst taking semaglutide for weight management.

Key Takeaways The U.S